FDA Inspection 829763 — Michigan Reproductive Medicine

Michigan Reproductive Medicine — FEI 3006074124

The FDA completed an inspection of Michigan Reproductive Medicine on April 1, 2013 in Bloomfield Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 1, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bloomfield Hills, MI (United States)